Anne‐Catrin Uhlemann

13.1k total citations · 4 hit papers
163 papers, 7.5k citations indexed

About

Anne‐Catrin Uhlemann is a scholar working on Infectious Diseases, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Anne‐Catrin Uhlemann has authored 163 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Infectious Diseases, 56 papers in Molecular Biology and 34 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Anne‐Catrin Uhlemann's work include Antimicrobial Resistance in Staphylococcus (32 papers), Antibiotic Resistance in Bacteria (31 papers) and Bacterial Identification and Susceptibility Testing (30 papers). Anne‐Catrin Uhlemann is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (32 papers), Antibiotic Resistance in Bacteria (31 papers) and Bacterial Identification and Susceptibility Testing (30 papers). Anne‐Catrin Uhlemann collaborates with scholars based in United States, United Kingdom and Germany. Anne‐Catrin Uhlemann's co-authors include Sanjeev Krishna, Angela Gomez‐Simmonds, Medini K. Annavajhala, Franklin D. Lowy, Richard K. Haynes, François Nosten, J. John Mann, Jeffrey M. Miller, Stephanie Cheung and M. Elizabeth Sublette and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Anne‐Catrin Uhlemann

154 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number

2004 616 citations Anne‐Catrin Uhlemann et al. profile →
Systematic Review of Gut Microbiota and Major Depression

2019 426 citations Stephanie Cheung, Anne‐Catrin Uhlemann et al. profile →
Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir

2022 260 citations Sho Iketani, Hiroshi Mohri et al. Nature profile →
Multidrug-resistant Gram-negative bacterial infections

2025 48 citations Nenad Maćešić, Anne‐Catrin Uhlemann et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne‐Catrin Uhlemann United States	49	2.3k	2.3k	2.2k	1.2k	1.1k	163	7.5k
Norio Ohmagari Japan	39	1.0k 0.4×	3.7k 1.6×	837 0.4×	1.1k 0.9×	1.5k 1.4×	509	7.3k
Guy Thwaites United Kingdom	65	1.3k 0.5×	6.4k 2.7×	1.5k 0.7×	1.8k 1.5×	4.4k 4.1×	310	14.3k
Elizabeth A. Ashley United Kingdom	48	5.9k 2.5×	920 0.4×	587 0.3×	404 0.3×	877 0.8×	178	8.0k
Yigang Tong China	42	516 0.2×	1.7k 0.7×	3.0k 1.3×	801 0.7×	978 0.9×	357	7.5k
Louis D. Saravolatz United States	41	690 0.3×	3.3k 1.4×	1.3k 0.6×	1.7k 1.5×	2.3k 2.2×	174	7.5k
Cheng‐Wen Lin Taiwan	44	858 0.4×	1.4k 0.6×	2.1k 1.0×	259 0.2×	564 0.5×	197	5.9k
Yoav Golan United States	31	407 0.2×	2.9k 1.2×	1.2k 0.5×	319 0.3×	2.2k 2.0×	73	5.4k
Jan Jacobs Belgium	44	2.2k 0.9×	1.3k 0.6×	773 0.3×	924 0.8×	1.6k 1.5×	265	7.1k
Melita A. Gordon United Kingdom	45	577 0.2×	2.5k 1.0×	1.2k 0.5×	1.0k 0.9×	1.1k 1.1×	175	8.6k
Kang Won Choe South Korea	41	640 0.3×	2.4k 1.0×	819 0.4×	1.6k 1.4×	1.9k 1.8×	131	6.0k

Countries citing papers authored by Anne‐Catrin Uhlemann

Since Specialization

Citations

This map shows the geographic impact of Anne‐Catrin Uhlemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne‐Catrin Uhlemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne‐Catrin Uhlemann more than expected).

Fields of papers citing papers by Anne‐Catrin Uhlemann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne‐Catrin Uhlemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne‐Catrin Uhlemann. The network helps show where Anne‐Catrin Uhlemann may publish in the future.

Co-authorship network of co-authors of Anne‐Catrin Uhlemann

This figure shows the co-authorship network connecting the top 25 collaborators of Anne‐Catrin Uhlemann. A scholar is included among the top collaborators of Anne‐Catrin Uhlemann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne‐Catrin Uhlemann. Anne‐Catrin Uhlemann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Annavajhala, Medini K., et al.. (2025). Hospital wastewater surveillance for SARS-CoV-2 identifies intra-hospital dynamics of viral transmission and evolution. Applied and Environmental Microbiology. 91(7). e0050125–e0050125.

Atta, Hussein, Heekuk Park, Djamila Eliby, et al.. (2025). Trending Microbiome Dysbiosis Over Time as an Early Assessment of Intestinal Transplant Rejection Risk. 6. 100123–100123.

Kubin, Christine J., et al.. (2025). Acinetobacter baumannii treatment strategies: a review of therapeutic challenges and considerations. Antimicrobial Agents and Chemotherapy. 69(8). e0106324–e0106324. 3 indexed citations

Spratlen, Miranda J., et al.. (2024). An evaluation of in utero polycyclic aromatic hydrocarbon exposure on the neonatal meconium microbiome. Environmental Research. 263(Pt 1). 120053–120053. 1 indexed citations

Zoccali, Marco, et al.. (2023). Role of Microbiome in the Outcomes Following Surgical Repair of Perianal Fistula: Prospective Cohort Study Design and Preliminary Results. World Journal of Surgery. 47(12). 3373–3379.

Bowen, Anthony, Jason Zucker, Yanhan Shen, et al.. (2022). Reduction in Risk of Death Among Patients Admitted With COVID-19 Between the First and Second Epidemic Waves in New York City. Open Forum Infectious Diseases. 9(9). ofac436–ofac436. 1 indexed citations

Iketani, Sho, Hiroshi Mohri, Bruce Culbertson, et al.. (2022). Multiple pathways for SARS-CoV-2 resistance to nirmatrelvir. Nature. 613(7944). 558–564. 260 indexed citations breakdown →

May, Michael, Michelle Chang, Donald Dietz, et al.. (2021). Limited Utility of Procalcitonin in Identifying Community-Associated Bacterial Infections in Patients Presenting with Coronavirus Disease 2019. Antimicrobial Agents and Chemotherapy. 65(4). 36 indexed citations

Sublette, M. Elizabeth, Stephanie Cheung, Evan Lieberman, et al.. (2021). Bipolar disorder and the gut microbiome: A systematic review. Bipolar Disorders. 23(6). 544–564. 51 indexed citations

10.

Kubin, Christine J., Thomas H. McConville, Donald Dietz, et al.. (2021). Characterization of Bacterial and Fungal Infections in Hospitalized Patients With Coronavirus Disease 2019 and Factors Associated With Health Care-Associated Infections. Open Forum Infectious Diseases. 8(6). ofab201–ofab201. 103 indexed citations

11.

McConville, Thomas H., Eloise D. Austin, Wenjing Geng, et al.. (2021). In Vitro Cytotoxicity and Clinical Correlates of MRSA Bacteremia. Antimicrobial Agents and Chemotherapy. 66(1). e0155921–e0155921. 3 indexed citations

12.

Tomlinson, Kira L., Tania Wong Fok Lung, Medini K. Annavajhala, et al.. (2021). Staphylococcus aureus induces an itaconate-dominated immunometabolic response that drives biofilm formation. Nature Communications. 12(1). 1399–1399. 94 indexed citations

13.

Annavajhala, Medini K., Hiroshi Mohri, Pengfei Wang, et al.. (2021). Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York. Nature. 597(7878). 703–708. 80 indexed citations

14.

Lagana, Stephen M., Satoru Kudose, Alina C. Iuga, et al.. (2020). Hepatic pathology in patients dying of COVID-19: a series of 40 cases including clinical, histologic, and virologic data. Modern Pathology. 33(11). 2147–2155. 167 indexed citations

15.

Papapanou, Panos N., Heekuk Park, Bin Cheng, et al.. (2020). Subgingival microbiome and clinical periodontal status in an elderly cohort: The WHICAP ancillary study of oral health. Journal of Periodontology. 91(S1). S56–S67. 51 indexed citations

16.

Austin, Eloise D., Nenad Maćešić, Monica Mehta, et al.. (2019). Reduced Mortality of Staphylococcus aureus Bacteremia in a Retrospective Cohort Study of 2139 Patients: 2007–2015. Clinical Infectious Diseases. 70(8). 1666–1674. 35 indexed citations

17.

Gustave, Claude-Alexandre, Anne Tristan, Patrícia Martins-Simões, et al.. (2018). Demographic fluctuation of community-acquired antibiotic-resistant Staphylococcus aureus lineages: potential role of flimsy antibiotic exposure. The ISME Journal. 12(8). 1879–1894. 10 indexed citations

18.

Nelson, Brian, Monica Mehta, Sarah Park, et al.. (2017). Piperacillin-Tazobactam versus Other Antibacterial Agents for Treatment of Bloodstream Infections Due to AmpC β-Lactamase-Producing Enterobacteriaceae. Antimicrobial Agents and Chemotherapy. 61(6). 71 indexed citations

19.

Gomez‐Simmonds, Angela, Yue Hu, Sean B. Sullivan, et al.. (2016). Evidence from a New York City hospital of rising incidence of genetically diverse carbapenem-resistantEnterobacter cloacaeand dominance of ST171, 2007–14. Journal of Antimicrobial Chemotherapy. 71(8). 2351–2353. 28 indexed citations

20.

Uhlemann, Anne‐Catrin, Janina Dordel, Justin Knox, et al.. (2014). Molecular tracing of the emergence, diversification, and transmission of S. aureus sequence type 8 in a New York community. Proceedings of the National Academy of Sciences. 111(18). 6738–6743. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact